HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 09, September 2019 – Healthy Ageing — How Science is chipping in       » Officials in China make progress in development of new drugs       » The Science of Healthy Ageing       » Thailand Medtech landscape - Customer to Innovator       » China-Thailand Joint Research Institute on Medicine Launched in Bangkok      
NEWS CRUNCH
Russia's only project to supply local high-tech anti-cancer drugs abroad continues with the first shipment to Vietnam
Russian biopharmaceutical company BIOCAD is the first company in the country to launch a 150-million-dollar effort to supply therapeutic products based on monoclonal antibodies to several countries outside Russia. In the end of December BIOCAD made its first shipment to Vietnam. The country received high-tech product for treatment of certain types of blood cancer. This was the first shipment under the 5-year contract with a local distributor. Previously, the Vietnamese patients could count only on the original products by Swiss global healthcare company F. Hoffmann-La Roche, but at a much higher price.

"Success of Russia's biosimilar rituximab has several ingredients. The product's high quality was proven in sizeable multinational clinical trials, yet its price is much lower than the originator's. This opened new opportunities to supply biosimilar rituximab to the patients who knew that the original product had been prohibitively expensive for them." Says BIOCAD's founder and CEO, Mr. Dmitri Morozov.

By now, BIOCAD has already signed more than a dozen agreements with the distribution and manufacturing companies in several countries of South-East Asia, such as the Philippines, Malaysia, Indonesia, and Thailand. Advanced Russian biotech products that are used for therapy of oncological and autoimmune diseases are in high demand WW. They are no inferior to the original products made by the leading Western companies, yet cost significantly less.

Source: BIOCAD
NEWS CRUNCH  
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
news Biofuel Producers and Users to Convene in Singapore for Global Biofuels Summit
news Philip Morris International opens artificial intelligence competition to develop improved strategies for medical diagnosis
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy